stockportfolio.pro
The Cooper Companies, Inc. (COO)
Healthcare · Medical Instruments & Supplies · NasdaqGS
The Cooper Companies, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.97B | $2.14B | $2.53B | $2.65B | $2.43B | $2.92B | $3.31B | $3.59B | $3.90B | $4.09B |
| Gross profit | $1.17B | $1.37B | $1.63B | $1.76B | $1.53B | $1.96B | $2.14B | $2.36B | $2.60B | $2.68B |
| Net income | $273.90M | $372.90M | $139.90M | $466.70M | $238.40M | $2.94B | $385.80M | $294.20M | $392.30M | $374.90M |
| Net margin | 13.9% | 17.4% | 5.5% | 17.6% | 9.8% | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% |
Source: The Cooper Companies, Inc. SEC filings (10-K). 18 years of history available in the interactive view.
What growth is priced into COO stock?
At today's market cap of $13.38B, The Cooper Companies, Inc. is priced for free-cash-flow growth of about 13.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $433.70M from the FY ending 2025-10-31). For comparison, free cash flow actually grew 19.7%/yr over the last five fiscal years and revenue 11%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 18 years of The Cooper Companies, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track COO in your portfolio →
The Cooper Companies, Inc. financial history by metric
About The Cooper Companies, Inc.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
The Cooper Companies, Inc. — frequently asked questions
What is The Cooper Companies, Inc.'s revenue?
The Cooper Companies, Inc. (COO) reported revenue of $4.09B for fiscal year 2025, up 5.1% from the prior year, according to its SEC filings.
Is The Cooper Companies, Inc. profitable?
Yes. COO earned net income of $374.90M in fiscal 2025, a net margin of 9.2%.
What is COO's P/E ratio?
The Cooper Companies, Inc. trades at a price-to-earnings ratio of about 58.2 based on the latest data in our nightly-refreshed cache.
How fast is The Cooper Companies, Inc. growing?
COO's revenue grew at roughly 11.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does The Cooper Companies, Inc. have?
As of fiscal year 2025, COO carried roughly $2.50B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is The Cooper Companies, Inc.'s gross margin?
COO's gross margin was 65.5% in fiscal 2025 — gross profit of $2.68B on revenue of $4.09B.
What is The Cooper Companies, Inc.'s market cap?
The Cooper Companies, Inc. (COO) has a market capitalization of about $13.38B, based on the latest data in our nightly-refreshed cache.
When does The Cooper Companies, Inc.'s fiscal year end?
COO's fiscal year ends in October. Its most recent annual filing covers the fiscal year ending 2025-10-31.
What growth is priced into COO stock?
At today's market cap of $13.38B, The Cooper Companies, Inc. is priced for free-cash-flow growth of about 13.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $433.70M from the FY ending 2025-10-31). For comparison, free cash flow actually grew 19.7%/yr over the last five fiscal years and revenue 11%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from The Cooper Companies, Inc.'s official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.